Marco Piscaglia

415 total citations
8 papers, 25 citations indexed

About

Marco Piscaglia is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marco Piscaglia has authored 8 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Marco Piscaglia's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Marco Piscaglia is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Marco Piscaglia collaborates with scholars based in Italy, Spain and South Africa. Marco Piscaglia's co-authors include Simone Passerini, Stefania Piconi, Matteo Passerini, Renata Grifantini, Lucia Galli, Laura Pezzati, Alessandra Bandera, Federico Conti, Emanuele Palomba and M. Allué López and has published in prestigious journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Resistance and Infection Control and Journal of Endocrinological Investigation.

In The Last Decade

Marco Piscaglia

7 papers receiving 24 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Piscaglia Italy	3	20	13	4	2	2	8	25
Stella Rousset France	3	17 0.8×	9 0.7×	4 1.0×	3 1.5×	1 0.5×	5	23
Michelle Lazzaro Switzerland	3	16 0.8×	24 1.8×	5 1.3×	2 1.0×		4	30
Zinhle Makatini South Africa	3	25 1.3×	6 0.5×	6 1.5×	2 1.0×	2 1.0×	9	27
Mpaphi B. Mbulawa United Kingdom	1	13 0.7×	10 0.8×	4 1.0×			2	13
Ruth Palmer United Kingdom	2	17 0.8×	10 0.8×	6 1.5×	1 0.5×		4	20
Anne Daguenel-Nguyen France	2	13 0.7×	11 0.8×	2 0.5×	1 0.5×	2 1.0×	3	22
Géraldine Colin France	2	10 0.5×	9 0.7×	4 1.0×			2	11
Krista Fischer Estonia	2	10 0.5×	17 1.3×	3 0.8×			2	22
Ф. И. Нагимова Russia	3	17 0.8×	16 1.2×	11 2.8×	3 1.5×	1 0.5×	14	31
Timothy Skalland United States	3	11 0.6×	8 0.6×	4 1.0×		1 0.5×	6	13

Countries citing papers authored by Marco Piscaglia

Since Specialization

Citations

This map shows the geographic impact of Marco Piscaglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Piscaglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Piscaglia more than expected).

Fields of papers citing papers by Marco Piscaglia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Piscaglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Piscaglia. The network helps show where Marco Piscaglia may publish in the future.

Co-authorship network of co-authors of Marco Piscaglia

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Piscaglia. A scholar is included among the top collaborators of Marco Piscaglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Piscaglia. Marco Piscaglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Piscaglia, Marco, et al.. (2025). Adequacy and implications of antimicrobial prophylaxis for elective surgeries in a tertiary hospital: a cross sectional and retrospective cohort study (ADEQUAP). Antimicrobial Resistance and Infection Control. 14(1). 82–82.

Piscaglia, Marco, Camilla Genovese, Renata Grifantini, et al.. (2025). Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials. Infectious Diseases and Therapy. 14(8). 1619–1647. 1 indexed citations

Piscaglia, Marco, Andrea Giacomelli, Davide Moschese, et al.. (2024). Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 97(4). e1–e5. 1 indexed citations

Piscaglia, Marco, Maria Vittoria Cossu, Matteo Passerini, et al.. (2021). Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials. Expert Opinion on Emerging Drugs. 26(3). 219–230. 2 indexed citations

Cattaneo, Dario, Luca Pasina, Federico Conti, et al.. (2021). Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience. Journal of Endocrinological Investigation. 44(12). 2849–2851. 3 indexed citations

Passerini, Matteo, et al.. (2020). Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak. Cureus. 12(5). e8254–e8254. 15 indexed citations

Capetti, Amedeo, Chiara Atzori, Maria Vittoria Cossu, et al.. (2019). Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?. Open Forum Infectious Diseases. 6(2). ofz044–ofz044. 1 indexed citations

Piscaglia, Marco, et al.. (1970). [Correlation between neoplasm mortality and the metal ion content of urban drinking water].. PubMed. 61(36). 1941–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact